false000182139300018213932021-08-272021-08-27

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
 ________________________________
 FORM 8-K
________________________________
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):    August 27, 2021 (August 25, 2021)
 THE AARON'S COMPANY, INC.
(Exact name of Registrant as Specified in Charter)
Georgia
1-39681
85-2483376
(State or other Jurisdiction of Incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)
400 Galleria Parkway SE Suite 300 Atlanta Georgia 30339-3194
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (678) 402-3000
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
        Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class  Trading Symbol Name of each exchange on which registered
Common Stock, $0.50 Par Value AAN  New York Stock Exchange



    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




ITEM 5.02.     DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On August 25, 2021, at the 2021 Annual Meeting of Shareholders (the “Annual Meeting”) of The Aaron's Company, Inc. (the “Company”) in Atlanta, Georgia, the shareholders of the Company, upon the recommendation of the Company’s Board of Directors, approved The Aaron's Company, Inc. Amended and Restated 2020 Equity and Incentive Plan (the “Amended and Restated 2020 Plan”). The Amended and Restated 2020 Plan became effective upon such shareholder approval.

The Amended and Restated 2020 Plan amends and restates in its entirety The Aaron’s Company, Inc. 2020 Equity and Incentive Plan (the “Original 2020 Plan”). In terms of material changes from the Original 2020 Plan:

The Amended and Restated 2020 Plan increases the number of shares of the Company’s common stock available for awards under the plan by 3,475,000 shares to a total of 6,775,000 shares.

The Amended and Restated 2020 Plan extends the term under which awards may be granted under the plan until August 24, 2031.

The Amended and Restated 2020 Plan includes a one-year minimum vesting requirement for all awards granted under it, subject to limited exceptions, as further described in the Amended and Restated 2020 Plan. The Original 2020 Plan only included a minimum vesting requirement with respect to performance shares and performance units, which minimum vesting requirement could be overridden in the discretion of the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”).

The Amended and Restated 2020 Plan now provides that dividends and dividend equivalents on all unvested awards granted under the Amended and Restated 2020 Plan will be subject to the same restrictions on vesting and payment as the awards to which they relate. The Original 2020 Plan limited this requirement to only certain types of awards. The Amended and Restated 2020 Plan does not allow for dividends or dividend equivalents on option or stock appreciation right awards.

The Amended and Restated 2020 Plan includes language clarifying that certain awards can provide for continued vesting (in addition to accelerated vesting) upon the occurrence of specified events.

The Amended and Restated 2020 Plan clarifies that the Compensation Committee may provide for the repayment to the Company of cash received with respect to an award under the plan in the event a participant engages in certain detrimental activity, as further described in the Amended and Restated 2020 Plan.

In addition to the changes described above, the Amended and Restated 2020 Plan includes various non-substantive conforming and clarifying changes.

The description of the Amended and Restated 2020 Plan is qualified in its entirety by reference to the full text of the Amended and Restated 2020 Plan, attached as Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed with the United States Securities and Exchange Commission (the “Commission”) on July 14, 2021, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.



ITEM 5.07.     SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
As described above, the Company held the Annual Meeting on August 25, 2021 in Atlanta, Georgia. As of June 21, 2021, the record date for the Annual Meeting, there were 33,861,982 shares of the Company’s common stock outstanding and entitled to vote at the Annual Meeting. A total of 31,048,098 shares of the Company’s common stock were represented at the Annual Meeting in person or by proxy, which was 91.69% of the aggregate number of shares of common stock entitled to vote at the Annual Meeting. At the Annual Meeting, the Company’s shareholders took the actions listed below and elected each of the director nominees to serve as directors until the expiration of such director’s term at the Company’s 2024 annual meeting of shareholders and until such director’s successor is duly elected and qualified, or until such director’s earlier resignation, removal from office or death, having cast the following votes:

Proposal 1 – Election of directors
For Against Abstain Non-Votes
Hubert L. Harris, Jr. 28,674,459  365,274  9,325  1,999,040 
John W. Robinson III 28,996,157  50,786  2,115  1,999,040 

Proposal 2 – Approval of a non-binding, advisory resolution to approve the Company’s executive compensation
For Against Abstain Non-Votes
28,216,785 810,741 21,532 1,999,040
    
Proposal 3 – Approval of a non-binding, advisory recommendation to the Board of Directors of the Company regarding the frequency of the advisory vote on executive compensation
One Year Two Years Three Years Abstain
27,538,187 13,922 1,477,901 19,048

Proposal 4 – Adopt and approve The Aaron's Company, Inc. Amended and Restated 2020 Equity and Incentive Plan
For Against Abstain Non-Votes
27,145,564 1,883,746 19,748 1,999,040

Proposal 5 – Ratification of the appointment of Ernst and Young LLP as the Company's independent registered public accounting firm for 2021
For Against Abstain Non-Votes
29,970,647 1,076,689 762






ITEM 9.01.     FINANCIAL STATEMENTS AND EXHIBITS

(d)    Exhibits:






SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE AARON'S COMPANY, INC.
By:
/s/ C. Kelly Wall
Date:
August 27, 2021
C. Kelly Wall
Chief Financial Officer



Aarons (NYSE:AAN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Aarons Charts.
Aarons (NYSE:AAN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Aarons Charts.